The FDA has delayed granting full approval of Novavax's COVID-19 vaccine despite it being on track to be cleared until Tuesday afternoon.

The lawmakers who introduced the bill say recent schemes have been brazen in their attempts to directly influence voters by offering cash in exchange for votes.